Fundraising Fox

Healthtech Investors & VC Firms in Belgium

49 firms in this list, with a median first check of $1M. 17 of them lead rounds. Generated from verified public data and updated continuously.

Debiopharm Innovation Fund
LausannePre-Seed–Late Stage$1M – $5M
13 people
Senovo
MunichSeed–Late Stage$1.1M – $5.4M
6 people
Fund+
LeuvenSeries A–Series B$5.5M – $16.5M
11 people
Newton Biocapital
BrusselsSeed–Series A
15 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries A–Late Stage
15 people
Red River West
Paris, Ile-De-FranceSeed–Growth$5.4M – $54M
7 people
Droia Ventures
LeuvenPre-Seed–Series B$540K
7 people
Alychlo
MerelbekeGrowth
15 people
Heran Partners
AntwerpSeed–Series B
12 people
Shaping Impact Group
BrusselsPre-Seed–Series B$270K – $1.6M
14 people
RDY Ventures
Pre-Seed–Seed$100K – $500K
13 people
Verto
ParisGrowth$16.2M – $64.8M
9 people
Novalis Biotech
GhentPre-Seed–Series A
9 people
PAI Partners
ParisGrowth–Late Stage$108M – $324M
8 people
Aescap Life Sciences
AmsterdamSeed–Growth
14 people
Eurazeo
ParisSeries A–Late Stage
12 people
Connect Ventures
LondonPre-Seed–Series A$500K – $5M
4 people
Ming capital
ShenzhenSeed–Late Stage
6 people
Vesalius Biocapital III Partners SàRL
ConternSeed–Late Stage$10.8M
12 people
VIVES Partners
WavrePre-Seed–Series B$108K – $7.6M
4 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
Catalpa Ventures
GrevenmacherPre-Seed–Series A$330K – $1.6M
5 people
Seido Capital
BrusselsPre-Seed–Late Stage$270K – $2.7M
3 people
Helsana HealthInvest AG
DübendorfSeed–Growth
4 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.